KEN LOCKE: Open Payments
NPI 1295032704 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,023 in 63 payments from 19 companies in 2025. Trend: 2023 $2,113 · 2024 $1,282 · 2025 $1,023
Food & beverage: $1,008Entertainment: $15
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 23 | $247 |
| Novo Nordisk Inc | 6 | $117 |
| Dexcom, Inc. | 3 | $63 |
| Lilly USA, LLC | 3 | $63 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $61 |
| Xeris Pharmaceuticals, Inc. | 3 | $58 |
| PFIZER INC. | 3 | $56 |
| Exact Sciences Corporation | 3 | $54 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| ABBVIE INC. | 3 | $50 |
Products named: OTEZLA, Dexcom G6 Transmitter, MOUNJARO, JARDIANCE, GVOKE HYPOPEN, The Cologuard Plus Collection Kit, REPATHA, Ozempic.
Industry payments across TX — which companies pay providers there.
